These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17639291)

  • 41. A chorioallantoic membrane model for the determination of anti-angiogenic effects of imatinib.
    Özcetin A; Aigner A; Bakowsky U
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):711-5. PubMed ID: 23891770
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-neovascular therapy using novel peptides homing to angiogenic vessels.
    Oku N; Asai T; Watanabe K; Kuromi K; Nagatsuka M; Kurohane K; Kikkawa H; Ogino K; Tanaka M; Ishikawa D; Tsukada H; Momose M; Nakayama J; Taki T
    Oncogene; 2002 Apr; 21(17):2662-9. PubMed ID: 11965539
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biomarkers for angiogenesis and antiangiogenic drugs in clinical oncology.
    Bertolini F
    Breast; 2009 Oct; 18 Suppl 3():S48-50. PubMed ID: 19914542
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
    Takahashi N; Haba A; Matsuno F; Seon BK
    Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Investigation of the Influence of Angiogenesis on Tumor Growth with the Use of a Mathematical Model].
    Kolobov AV; Kuznetsov MB
    Biofizika; 2015; 60(3):555-63. PubMed ID: 26349221
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Angiogenesis and neoangiogenesis--the role in lung cancer and other tumors].
    Swidzińska E; Naumnik W; Chyczewska E
    Pneumonol Alergol Pol; 2006; 74(4):414-20. PubMed ID: 17427152
    [No Abstract]   [Full Text] [Related]  

  • 47. Imaging the effects of anti-angiogenic treatments.
    Vāvere AL; Lewis JS
    Q J Nucl Med; 2003 Sep; 47(3):163-70. PubMed ID: 12897708
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Surgical procedure as an inducer of tumor angiogenesis.
    Kong B; Michalski CW; Friess H; Kleeff J
    Exp Oncol; 2010 Sep; 32(3):186-9. PubMed ID: 21403615
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of thalidomide in hepatocellular carcinoma: assessment with power doppler US and analysis of circulating angiogenic factors.
    Hsu C; Chen CN; Chen LT; Wu CY; Hsieh FJ; Cheng AL
    Radiology; 2005 May; 235(2):509-16. PubMed ID: 15858091
    [TBL] [Abstract][Full Text] [Related]  

  • 50. LHT7, a chemically modified heparin, inhibits multiple stages of angiogenesis by blocking VEGF, FGF2 and PDGF-B signaling pathways.
    Chung SW; Bae SM; Lee M; Al-Hilal TA; Lee CK; Kim JK; Kim IS; Kim SY; Byun Y
    Biomaterials; 2015 Jan; 37():271-8. PubMed ID: 25453957
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Imaging techniques used for the real-time assessment of angiogenesis in digestive cancers.
    Săftoiu A; Vilmann P
    World J Gastroenterol; 2011 Jan; 17(1):7-8. PubMed ID: 21218077
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-angiogenesis as a new concept for the therapy of neovascular diseases.
    Schweigerer L
    Klin Wochenschr; 1991 Jul; 69(10):417-8. PubMed ID: 1719269
    [No Abstract]   [Full Text] [Related]  

  • 53. Advances in angiogenesis research: relevance to urological oncology.
    Campbell SC
    J Urol; 1997 Nov; 158(5):1663-74. PubMed ID: 9334575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Imaging and other biomarkers in early clinical studies: one step at a time or re-engineering drug development?
    Collins JM
    J Clin Oncol; 2005 Aug; 23(24):5417-9. PubMed ID: 16027435
    [No Abstract]   [Full Text] [Related]  

  • 55. Diagnostic and Therapeutic Values of Angiogenic Factors in Endometrial Cancer.
    Roškar L; Roškar I; Rižner TL; Smrkolj Š
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053155
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiogenesis in urological malignancy.
    O'Brien TS; Harris AL
    Br J Urol; 1995 Dec; 76(6):675-82. PubMed ID: 8535707
    [No Abstract]   [Full Text] [Related]  

  • 57. Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging.
    Jackson A; O'Connor JP; Parker GJ; Jayson GC
    Clin Cancer Res; 2007 Jun; 13(12):3449-59. PubMed ID: 17575207
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Real-Time Longitudinal Evaluation of Tumor Blood Vessels Using a Compact Preclinical Fluorescence Imaging System.
    Jeong H; Kim SR; Kang Y; Kim H; Kim SY; Cho SH; Kim KN
    Biosensors (Basel); 2021 Nov; 11(12):. PubMed ID: 34940228
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The use of microvessel density in assessing human urological tumours.
    Goddard JC; Sutton CD; Berry DP; O'Byrne KJ; Kockelbergh RC
    BJU Int; 2001 Jun; 87(9):866-75. PubMed ID: 11412229
    [No Abstract]   [Full Text] [Related]  

  • 60. Imaging of angiogenesis in cardiology.
    Higuchi T; Wester HJ; Schwaiger M
    Eur J Nucl Med Mol Imaging; 2007 Jun; 34 Suppl 1():S9-19. PubMed ID: 17479264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.